Previous studies have confirmed that the activation of STAT3 is related to the poor prognosis of tumors, including head and neck tumors, B-cell lymphoma, cervical cancer, gastric cancer, colon cancer, liver cancer, glioma and esophageal cancer [28]. Here, STAT3 is linked to B-cell non-Hodgkin lymphoma.